PO.CL01.12 · 临床研究

SPACE:用于三维模型中高通量CRISPR筛选的空间分辨多组学分析

SPACE: Spatially resolved multiomic analysis for high-throughput CRISPR screening in 3D models

海报缩略图:SPACE:用于三维模型中高通量CRISPR筛选的空间分辨多组学分析
编号 1214 展板 15 时间 4/19 02:00–05:00 区域 Section 47 主讲 Mengwei Hu, PhD
分会场 Spatial Proteomics and Transcriptomics 1
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Mengwei Hu1, Yi Cui2, Qianhui Huang1, Khoi Chu1, Sierra McKinzie2, Michael Patrick2, Sharanya Iyengar1, Maerjianghan Abuduli1, Marianne Spatz1, Nandita Joshi1, Brendan Miller1, Shams Vellarikkal1, Timothy Riordan2, Danny Bitton3, Jan Lubojacky3, Iya Khalil1, Federica Piccioni1, Michael Rhodes2, Alex Tamburino1, Shanshan He2, Joseph Beechem2, Vanessa Peterson1

1Merck & Co., Inc, Cambridge, MA,2Bruker Spatial Biology, Seattle, WA,3MSD, Prague, Czech Republic

摘要 Abstract

中文摘要
高内涵单细胞扰动筛选对于阐明基因功能和揭示新生物学至关重要,但传统方法需要细胞解离,丧失了在复杂微环境中剖析细胞-细胞相互作用和组织结构所必需的关键空间信息。虽然空间CRISPR筛选部分缓解了这一问题,但现有技术受限于基于假设的表型面板,仅限于稀疏的RNA或蛋白覆盖,制约了全面的基因功能评估和发现广度。为克服这些障碍,我们开发了SPACE(SPAtial Cell Exploration),这是一个开创性平台,在完整的三维组织背景中以单细胞分辨率融合了全转录组图谱、CRISPR扰动和多重蛋白检测。SPACE提供无偏的、全转录组范围的读出,同时兼容多达76个蛋白标志物,极大地扩展了空间筛选中的表型图景。作为迄今最高通量的多模态空间CRISPR检测,SPACE以前所未有的规模和可负担性实现了这一点,并在效率上大幅优于基于测序的替代方案。我们将SPACE应用于与肿瘤细胞在三维球体中共培养的癌相关成纤维细胞(CAF)的42个基因扰动,从数百个球体中产生了多维多组学数据集。高置信度的向导RNA检测与稳健的内源mRNA表征相结合。无偏分析揭示了关于CAF-肿瘤动态的新见解:细胞外基质(ECM)重塑、空间分辨的配体-受体相互作用以及扰动特异性的基因变异性。值得注意的是,CAF中ISG20敲除深刻抑制了多种基质金属蛋白酶——一个经正交验证的未报道关联——提示ISG20参与新型ECM调控和肿瘤进展。一些扰动被进一步揭示可重塑细胞间信号,揭示了依赖敲除的空间配体-受体转变和协调的表达特征,凸显了肿瘤表型中的微环境串扰。作为里程碑式的演示,SPACE在一张玻片上同时捕获了全转录组、CRISPR身份和68个蛋白标志物,实现了全面的扰动表型分析。这项变革性技术将空间CRISPR筛选推进到转化领域,促进了在模拟人体组织复杂性的多细胞模型中进行靶点和生物标志物识别。通过在转录组尺度上将高通量扰动与空间分辨多组学相结合,SPACE催化了异质组织中的发现。SPACE数据集将助力生成式AI模型进行因果生物学推断,加速药物发现和精准医学。
查看英文原文 English abstract
High-content single-cell perturbation screens are pivotal for elucidating gene functions and uncovering novel biology, yet conventional methods necessitate cell dissociation, forfeiting critical spatial information essential for dissecting cell-cell interactions and tissue architecture in complex microenvironments. While spatial CRISPR screening mitigates this partially, existing technologies are constrained by hypothesis-driven phenotyping panels limited to sparse RNA or protein coverage, curtailing comprehensive gene function assessment and discovery breadth.To overcome these barriers, we developed SPACE ( SPA tial C ell E xploration), a pioneering platform that fuses whole-transcriptome profiling, CRISPR perturbations, and multiplexed protein detection at single-cell resolution within intact 3D tissue contexts. SPACE delivers unbiased, transcriptome-wide readouts alongside compatibility for up to 76 protein markers, vastly expanding phenotypic landscapes in spatial screens. As the highest-plex multimodal spatial CRISPR assay to date, SPACE achieves this at unprecedented scale and affordability and largely outperforms sequencing-based alternatives in efficiency.We applied SPACE across 42 gene perturbations in cancer-associated fibroblasts (CAFs) co-cultured with tumor cells in 3D spheroids, yielding multidimensional multiomic datasets from hundreds of spheroids. High-confidence guide RNA detection was coupled with robust endogenous mRNA characterization. Unbiased analyses uncovered new insights on CAF-tumor dynamics: extracellular matrix (ECM) remodeling, spatially resolved ligand-receptor interactions, and perturbation-specific gene variability.Notably, ISG20 knockout in CAFs profoundly suppressed multiple matrix metalloproteinases - an unreported link validated orthogonally - implicating ISG20 in novel ECM regulation and tumor progression. Some perturbations were further revealed to reshape intercellular signaling, revealing knockout-dependent spatial ligand-receptor shifts and coordinated expression signatures that underscore microenvironmental crosstalk in tumor phenotypes.Culminating in a landmark demonstration, SPACE simultaneously captured whole transcriptomes, CRISPR identities, and 68 protein markers on one slide, enabling holistic perturbation phenotyping. This transformative technology propels spatial CRISPR screening into translational realms, facilitating target and biomarker identification in multicellular models mirroring human tissue intricacy. By merging high-throughput perturbations with spatially resolved multiomics at transcriptome scale, SPACE catalyzes discovery in heterogeneous tissues. SPACE datasets will fuel generative AI models for causal biology inference, accelerating drug discovery and precision medicine.
利益披露 Disclosure
M. Hu, Merck & Co., Inc Employment. Y. Cui, Bruker Spatial Biology Employment. Q. Huang, Merck & Co., Inc Employment. K. Chu, Merck & Co., Inc Employment. S. McKinzie, Bruker Spatial Biology Employment. M. Patrick, Bruker Spatial Biology Employment. S. Iyengar, Merck & Co., Inc Employment. M. Abuduli, Merck & Co., Inc Employment. M. Spatz, Merck & Co., Inc Employment. N. Joshi, Merck & Co., Inc Employment. B. Miller, Merck & Co., Inc Employment. S. Vellarikkal, Merck & Co., Inc Employment. T. Riordan, Bruker Spatial Biology Employment. D. Bitton, MSD Employment. J. Lubojacky, MSD Employment. I. Khalil, Merck & Co., Inc Employment. F. Piccioni, Merck & Co., Inc Employment. M. Rhodes, Bruker Spatial Biology Employment. A. Tamburino, Merck & Co., Inc Employment. S. He, Bruker Spatial Biology Employment. J. Beechem, Bruker Spatial Biology Employment. V. Peterson, Merck & Co., Inc Employment.

← 返回 AACR 2026 检索